1 / 2

Contraceptives Market Size & Share

Contraceptives Market

Manisha109
Download Presentation

Contraceptives Market Size & Share

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Contraceptives Market Analysis The global contraceptives market, valued at USD 22.49 billion in 2019, is projected to reach USD 30.15 billion by 2027, growing at a 5.5% CAGR. Market Leadership & Regional Dominance North America leads the market with a 43.17% share, driven by high unintended pregnancy rates and strong presence of major pharmaceutical companies. The U.S. market is particularly notable, with 45% of 6.1 million annual pregnancies being unwanted. Key Market Segments By Product  Contraceptive Drugs: Holds the largest market share  Contraceptive Devices: Expected to show faster growth through 2027 By Distribution Channel  Retail Pharmacies: Dominant segment due to robust supply chain networks  Hospital Pharmacies: Expected to hold 31.4% share by 2025  Online Channels: Growing due to increased OTC drug accessibility Regional Growth Trends  China: Projected 7.20% CAGR, driven by population size and family planning initiatives  Japan: Market expected to reach USD 1.05 billion by 2025  Europe: 5.6% CAGR forecast, fueled by teen pregnancy rates and clinical trial funding COVID-19 Impact The pandemic has disrupted contraceptive access significantly. According to U.N. Population Fund data, 47 million women in low and middle-income countries faced potential inability to access contraception during lockdowns, risking 7 million unintended pregnancies. Market Leaders Top companies dominating the market:  Pfizer, Inc. (U.S.)  Bayer AG (Germany)  Merck & Co., Inc. (U.S.) Recent Developments  June 2021: Emme launched EmmeRx, expanding into prescription delivery and telemedicine  April 2021: Mayne Pharma received FDA approval for NEXTSTELLIS  March 2021: Clue introduced digital contraceptive with ovulation prediction

  2. May 2020: Evofem Biosciences received FDA approval for Phexxi, the first non-hormonal birth control gel Report- Fortune Business Insights - Contraceptives Market Size, Share, Growth, Trends Report, 2027 https://www.fortunebusinessinsights.com/industry-reports/contraceptives-market-100064

More Related